| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/12/2001 | US6245561 For inducement of cell differentiation, and enhancement of cell phenotypic expression, vitality, longevity, and production; differentiation of precursor cells into specialized cells; autoimmune diseases |
| 06/12/2001 | US6245365 Arachidonic acid |
| 06/12/2001 | US6245364 Weight reduction method for cats and other pets |
| 06/12/2001 | US6245362 Medication for treatment of viral disease based on active agents of plant hypericum (St. John's Wort) and method of production of the medication |
| 06/12/2001 | US6245359 Active agent transport systems |
| 06/12/2001 | US6245358 Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation |
| 06/12/2001 | US6245357 Extended release dosage form |
| 06/12/2001 | US6245355 Sustained release matrix for high-dose insoluble drugs |
| 06/12/2001 | US6245353 Mixing with effervescent base |
| 06/12/2001 | US6245352 Pharmaceutical formulation |
| 06/12/2001 | US6245351 Controlled-release composition |
| 06/12/2001 | US6245348 Topical, therapeutic composition for external use and method of treatment |
| 06/12/2001 | US6245347 Controlling absorption by controlling temperature |
| 06/12/2001 | US6245336 Administering plant extract |
| 06/12/2001 | US6245330 Recombinant adenoviruses coding for glial-derived neurotrophic factor (GDNF) |
| 06/12/2001 | US6245326 Health supplement |
| 06/12/2001 | US6244265 Adhesively applied external nasal strips and dilators containing medications and fragrances |
| 06/12/2001 | CA2215982C Nodulisporic acid derivatives |
| 06/12/2001 | CA2195031C Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient |
| 06/12/2001 | CA2171453C Glutathione analogs and paralog panels comprising glutathione mimics |
| 06/12/2001 | CA2125665C Medicaments |
| 06/12/2001 | CA2085366C Novel polyamines and method for preparation thereof |
| 06/12/2001 | CA2080917C New pharmacologically active catechol derivatives |
| 06/12/2001 | CA2077762C New use of bambuterol |
| 06/12/2001 | CA2072123C Inhibitors of purine nucleoside phosphorylase |
| 06/12/2001 | CA2071408C Tablet for slow release of indapamine after oral administration |
| 06/12/2001 | CA2046857C Morpholinyl derivatives of doxorubicin and process for their preparation |
| 06/12/2001 | CA2046002C Purinyl and pyrimidinyl tetrahydrofurans |
| 06/12/2001 | CA2019957C Heteroarylamino- and heteroaryloxypyridinamines and related compounds, a process for their preparation and their use as dermatological agents |
| 06/12/2001 | CA2014544C Bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 06/12/2001 | CA2003388C Neuroprotective pharmaceutical compositions containing arylcyclohexylamines |
| 06/11/2001 | WO2001044230A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 06/11/2001 | CA2393310A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 06/10/2001 | CA2327946A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/10/2001 | CA2327925A1 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/10/2001 | CA2292247A1 Chronotherapeutic formulations of diltiazem and the administration thereof |
| 06/08/2001 | CA2291959A1 A nutriceutical composition of l-carnitine, ubiquinone, n-3 polyunsaturated fatty acids and vitamins specifically formulated at pharmacological doses for the amelioration of the risk factors and symptoms of atherosclerosis-related illnesses |
| 06/07/2001 | WO2001040988A1 Web map tool |
| 06/07/2001 | WO2001040521A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | WO2001040497A2 Method for obtaining nucleic acids from an environment sample |
| 06/07/2001 | WO2001040471A1 Antigenic protein lppq of mycoplasma mycoidessubsp.(mycoides)sc., its preparation and use |
| 06/07/2001 | WO2001040456A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040455A2 Compositions and methods for increasing packaging and yields of recombinant adenoviruses using multiple packaging signals |
| 06/07/2001 | WO2001040451A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | WO2001040442A1 Novel bacterial isolate and the preparation and use of its active metabolites |
| 06/07/2001 | WO2001040438A2 Methods and compositions for regulating lymphocyte activity |
| 06/07/2001 | WO2001040348A2 Amorphous polymeric polyaxial initiators and compliant crystalline copolymers therefrom |
| 06/07/2001 | WO2001040316A1 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
| 06/07/2001 | WO2001040309A2 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 06/07/2001 | WO2001040303A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | WO2001040271A2 Cancer associated antigens and uses therefor |
| 06/07/2001 | WO2001040255A2 14,15-beta-methylene substituted androgens |
| 06/07/2001 | WO2001040253A2 3-methylene steroid derivative for the treatment of autoimmune diseases |
| 06/07/2001 | WO2001040251A1 Transforming growth factor alpha hiii |
| 06/07/2001 | WO2001040246A1 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
| 06/07/2001 | WO2001040243A2 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
| 06/07/2001 | WO2001040242A2 6-o-methylerythromycin a crystal form iii |
| 06/07/2001 | WO2001040241A2 6-o-alkyl-2-nor-2-substituted ketolide derivatives |
| 06/07/2001 | WO2001040239A2 Transition metal-cyclopentadienyl-tropane conjugates |
| 06/07/2001 | WO2001040232A1 Chlorophyll and bacteriochlorophyll esters, and their preparation |
| 06/07/2001 | WO2001040231A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 06/07/2001 | WO2001040230A1 Pyrazolopyrazines and their use as adenosine antagonists |
| 06/07/2001 | WO2001040229A2 Method for producing epinastine hydrochloride in the high-melting crystal modification |
| 06/07/2001 | WO2001040226A1 Agents for improving learning or memory |
| 06/07/2001 | WO2001040225A1 Remedies or preventives for frequent urination or urinary incontinence |
| 06/07/2001 | WO2001040223A2 Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 06/07/2001 | WO2001040222A1 Substituted isoxazolines and their use as antibacterial agents |
| 06/07/2001 | WO2001040218A1 Arylamine derivatives and their use as anti-telomerase agent |
| 06/07/2001 | WO2001040217A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 06/07/2001 | WO2001040216A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | WO2001040215A1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 06/07/2001 | WO2001040214A1 Bryostatin analogues, synthetic methods and uses |
| 06/07/2001 | WO2001040213A1 Neutralizing agent for toxin of microorganism belonging to the genus clostridium |
| 06/07/2001 | WO2001040211A1 A PROCESS FOR THE PREPARATION OF {2-[4-(α-PHENYL-p-CHLOROBENZYL)PIPERAZIN-1-YL]ETHOXY}ACETIC ACID AND NOVEL INTERMEDIATES THEREFOR |
| 06/07/2001 | WO2001040210A1 Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same |
| 06/07/2001 | WO2001040207A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators |
| 06/07/2001 | WO2001040206A1 Pesticidal n-heteroaryl alpha-alkoximino-carboxamides |
| 06/07/2001 | WO2001040201A1 Oxazolidinone derivatives |
| 06/07/2001 | WO2001040196A1 2-amino-5,6-dihalo-3,4-dihydroquinazolines with blood platelet reducing properties |
| 06/07/2001 | WO2001040195A2 Control of arthropods in animals |
| 06/07/2001 | WO2001040192A1 Novel heterocyclic compounds and salts thereof and medicinal use of the same |
| 06/07/2001 | WO2001040190A1 4-carboxyamino-2-ethyl-1,2,3,4-tetrahydroquinoline crystal as cetp inhibitor |
| 06/07/2001 | WO2001040189A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 06/07/2001 | WO2001040188A1 Curcumin analogues for treating cancer |
| 06/07/2001 | WO2001040187A2 Compound having effect of promoting neuron differentiation |
| 06/07/2001 | WO2001040185A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 06/07/2001 | WO2001040182A2 Solid pharmaceutical preparation |
| 06/07/2001 | WO2001040181A1 Acryloyl peptidic derivatives, process for their preparation and their use as antitumor agents |
| 06/07/2001 | WO2001040180A2 N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents |
| 06/07/2001 | WO2001040172A1 New tri-substituted phenyl derivatives and analogues |
| 06/07/2001 | WO2001040171A1 Crystalline form of (s)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid |
| 06/07/2001 | WO2001040170A1 New phenalkyloxy-phenyl derivatives |
| 06/07/2001 | WO2001040169A1 Comminuted form of (s)-2-ethoxy -3-[4-(2- {4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid |
| 06/07/2001 | WO2001040166A1 Comminuted form of 3-{4-[2-(4-tert-butoxycarbonylaminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic |
| 06/07/2001 | WO2001040165A1 Crystalline form of 3-{4-[2-(4-tert-butoxycarbonylaminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid |
| 06/07/2001 | WO2001039836A1 A rapid acting freeze dired oral pharmaceutical composition for treating migraine |
| 06/07/2001 | WO2001039812A1 A bioabsorbable drug delivery system |
| 06/07/2001 | WO2001039805A1 Concomitant drugs for treating glaucoma |
| 06/07/2001 | WO2001039804A2 Gd3 synthesis inhibitors for treating neuropathological disorders |
| 06/07/2001 | WO2001039789A1 Carbon dioxide enhancement of inhalation therapy |